TOLERABILITY AND SAFETY OF FELODIPINE

被引：5

作者：

ELVELIN, L ^{[1
]}

KENNERFALK, A ^{[1
]}

ELMFELDT, D ^{[1
]}

机构：

[1] ASTRA HASSLE AB, DEPT CARDIOVASC MED, S-43183 MOLNDAL, SWEDEN

来源：

CARDIOVASCULAR DRUG REVIEWS | 1993年 / 11卷 / 01期

关键词：

FELODIPINE; TOLERABILITY; SAFETY; HYPERTENSION; ADVERSE DRUG REACTION; QUALITY OF LIFE; DRUG INTERACTION;

D O I：

10.1111/j.1527-3466.1993.tb00271.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：126 / 147

页数：22

共 114 条

[21] DIGITAL DEFECTS INDUCED BY VASODILATING AGENTS - RELATIONSHIP TO REDUCTION IN UTEROPLACENTAL BLOOD-FLOW [J].

DANIELSSON, BRG ;

REILAND, S ;

RUNDQVIST, E ;

DANIELSON, M .

TERATOLOGY, 1989, 40 (04) :351-358

[22] ORAL NIFEDIPINE FOR THE TREATMENT OF PATIENTS WITH SEVERE HYPERTENSION [J].

DAVIDSON, RC ;

BURSTEN, SL ;

KEELEY, PA ;

KENNY, MA ;

STEWART, DK .

AMERICAN JOURNAL OF MEDICINE, 1985, 79 (4A) :26-30

[23]

DEGAUDEMARIS R, 1991, MAL COEUR VAISS, V84, P45

[24]

DIMENAS E, 1991, EUR J CLIN PHARMACOL, V40, P141

[25] FELODIPINE CLINICAL PHARMACOKINETICS [J].

DUNSELMAN, PHJM ;

EDGAR, B .

CLINICAL PHARMACOKINETICS, 1991, 21 (06) :418-430

[26] DIGOXIN-FELODIPINE INTERACTION IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].

DUNSELMAN, PHJM ;

SCAF, AHJ ;

KUNTZE, CEE ;

LIE, KI ;

WESSELING, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (05) :461-465

[27] EFFICACY OF FELODIPINE IN CONGESTIVE HEART-FAILURE [J].

DUNSELMAN, PHJM ;

KUNTZE, CEE ;

VANBRUGGEN, A ;

HAMER, JPM ;

SCAF, AHJ ;

WESSELING, H ;

LIE, KI .

EUROPEAN HEART JOURNAL, 1989, 10 (04) :354-364

[28]

EDGAR B, 1990, CLIN PHARMACOL THER, V47, P181

[29]

ELMFELDT D, 1992, KIDNEY INT, V41, pS54

[30]

ELMFELDT D, 1989, 4TH INT S CALC ANT P

← 1 2 3 4 5 6 7 8 9 10 →